Our findings indicate that appropriate manipulation of telomere/TRF2 shelterin machinery may restore T-cell competency and prevent premature immune senescence, thus providing a new strategy to improve immunotherapy and vaccine responses against human viral diseases. This evidence concerns the gene TERF2 and viral infectious disease.